Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002619 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Hongjian Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Department of Clinical Oncology, Renmin Hospita…. Hauptthemen laut MEDLINE: Dependovirus, Gene Editing, Genetic Vectors, CRISPR-Cas Systems. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds.
Abstract (Originalsprache)
The CRISPR-associated endonuclease Cas12a has become a powerful genome-editing tool in biomedical research due to its ease of use and low off-targeting. However, the size of Cas12a severely limits clinical applications such as adeno-associated virus (AAV)-based gene therapy. Here, we characterized a novel compact Cas12a ortholog, termed EbCas12a, from the metagenome-assembled genome of a currently unclassified Erysipelotrichia . It has the PAM sequence of 5′-TTTV-3′ (V = A, G, C) and the smallest size of approximately 3.47 kb among the Cas12a orthologs reported so far. In addition, enhanced EbCas12a (enEbCas12a) was also designed to have comparable editing efficiency with higher specificity to AsCas12a and LbCas12a in mammalian cells at multiple target sites. Based on the compact enEbCas12a, an all-in-one AAV delivery system with crRNA for Cas12a was developed for both in vitro and in vivo applications. Overall, the novel smallest high-fidelity enEbCas12a, this first case of the all-in-one AAV delivery for Cas12a could greatly boost future gene therapy and scientific research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Department of Clinical Oncology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
ORCID-Profile: Lei Yin
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds
- China Postdoctoral Science Foundation
- the National Key R&D Program of China
- the National Natural Science Foundation of China
- the Fundamental Research Funds for the Central Universities
- the China Postdoctoral Science Foundation
Zitieren
APA
Wang, H., Zhou, J., Lei, J., Mo, G., Wu, Y., Liu, H., Pang, Z., Du, M., Zhou, Z., Paek, C., Sun, Z., Chen, Y., Wang, Y., Chen, P., & Yin, L. (2024). Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002619
Vancouver
Wang H, Zhou J, Lei J, Mo G, Wu Y, Liu H, et al. Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002619
BibTeX
@article{Wang2024,
author = {Wang, Hongjian and Zhou, Jin and Lei, Jun and Mo, Guosheng and Wu, Yankang and Liu, Huan and Pang, Ziyan and Du, Mingkun and Zhou, Zihao and Paek, Chonil and Sun, Zaiqiao and Chen, Yongshun and Wang, Yan and Chen, Peng and Yin, Lei},
title = {Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002619}
}
EUVIMED